Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...

Texas has one of the highest rates of diabetes in the country, with more than 2.7 million Texans diagnosed with the condition ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 diabetics, a new study has found. It highlights the fundamental difference ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

By Camille White OSD Communications Specialist The Oxford School District has implemented iPads at each of its ...

High intake of calorie-dense diets, increased screen time, lack of sleep, and rising stress are identified as key factors for ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...